Masked Hypertension and Cardiovascular Disease Events in a Prospective Cohort of Blacks: The Jackson Heart Study

Masked hypertension, defined as nonelevated clinic blood pressure (BP) with elevated out-of-clinic BP, has been associated with increased cardiovascular disease (CVD) risk in Europeans and Asians. Few data are available on masked hypertension and CVD and mortality risk among blacks. We analyzed data from the Jackson Heart Study, a prospective cohort study of blacks. Analyses included participants with clinic-measured systolic/diastolic BP <140/90 mm Hg who completed ambulatory BP monitoring after the baseline examination in 2000 to 2004 (n=738). Masked daytime (10:00 AM–8:00 PM) hypertension was defined as mean ambulatory systolic/diastolic BP ≥135/85 mm Hg. Masked nighttime (midnight to 6:00 AM) hypertension was defined as mean ambulatory systolic/diastolic BP ≥120/70 mm Hg. Masked 24-hour hypertension was defined as mean systolic/diastolic BP ≥130/80 mm Hg. CVD events (nonfatal/fatal stroke, nonfatal myocardial infarction, or fatal coronary heart disease) and deaths identified through December 2010 were adjudicated. Any masked hypertension (masked daytime, nighttime, or 24-hour hypertension) was present in 52.2% of participants; 28.2%, 48.2% and 31.7% had masked daytime, nighttime, and 24-hour hypertension, respectively. There were 51 CVD events and 44 deaths during a median follow-up of 8.2 and 8.5 years, respectively. CVD rates per 1000 person-years (95% confidence interval) in participants with and without any masked hypertension were 13.5 (9.9–18.4) and 3.9 (2.2–7.1), respectively. The multivariable adjusted hazard ratio (95% confidence interval) for CVD was 2.49 (1.26–4.93) for any masked hypertension and 2.86 (1.59–5.13), 2.35 (1.23–4.50), and 2.52 (1.39–4.58) for masked daytime, nighttime, and 24-hour hypertension, respectively. Masked hypertension was not associated with all-cause mortality. Masked hypertension is common and associated with increased risk for CVD events in blacks.

[1]  A. Viera,et al.  Evaluation of Criteria to Detect Masked Hypertension , 2016, Journal of clinical hypertension.

[2]  A. Siu Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. , 2015, Annals of internal medicine.

[3]  P. Dubbert,et al.  Prevalence, Determinants, and Clinical Significance of Masked Hypertension in a Population-Based Sample of African Americans: The Jackson Heart Study. , 2015, American journal of hypertension.

[4]  C. Lewis,et al.  Racial differences in abnormal ambulatory blood pressure monitoring measures: Results from the Coronary Artery Risk Development in Young Adults (CARDIA) study. , 2015, American journal of hypertension.

[5]  Mark D. Huffman,et al.  AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .

[6]  Simon L Bacon,et al.  The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. , 2013, The Canadian journal of cardiology.

[7]  J. Banegas,et al.  High prevalence of masked uncontrolled hypertension in people with treated hypertension. , 2014, European heart journal.

[8]  J. Redón,et al.  Ambulatory Blood Pressure Monitoring Is Ready to Replace Clinic Blood Pressure in the Diagnosis of Hypertension: Con Side of the Argument , 2014, Hypertension.

[9]  Prevalence of Masked Hypertension in African Americans , 2014, Journal of clinical hypertension.

[10]  E. O’Brien,et al.  Setting Thresholds to Varying Blood Pressure Monitoring Intervals Differentially Affects Risk Estimates Associated With White-Coat and Masked Hypertension in the Population , 2014, Hypertension.

[11]  J. Schwartz,et al.  Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions , 2014, Journal of Human Hypertension.

[12]  H. Matsuoka [Masked hypertension]. , 2014, Nihon rinsho. Japanese journal of clinical medicine.

[13]  Geoffrey A Head,et al.  European Society of Hypertension position paper on ambulatory blood pressure monitoring. , 2013, Journal of hypertension.

[14]  A. Folsom,et al.  Physical activity and cardiovascular disease in African Americans in Atherosclerosis Risk in Communities. , 2013, Medicine and science in sports and exercise.

[15]  Joseph E Schwartz,et al.  Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study. , 2012, American journal of hypertension.

[16]  E. O’Brien,et al.  Significance of White-Coat Hypertension in Older Persons With Isolated Systolic Hypertension: A Meta-Analysis Using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Population , 2012, Hypertension.

[17]  A. Kashem,et al.  Endothelial-dependent flow-mediated dilation in African Americans with masked-hypertension. , 2011, American journal of hypertension.

[18]  Patrick Royston,et al.  Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.

[19]  F. Cuccurullo,et al.  Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. , 2011, American journal of hypertension.

[20]  G. Reboldi,et al.  Masked hypertension: evaluation, prognosis, and treatment. , 2010, American journal of hypertension.

[21]  G. Reboldi,et al.  Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring , 2009, Hypertension.

[22]  G. Parati,et al.  Why Is Out-of-Office Blood Pressure Measurement Needed?: Home Blood Pressure Measurements Will Increasingly Replace Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Hypertension , 2009, Hypertension.

[23]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[24]  Mahboob Rahman,et al.  Disparate Estimates of Hypertension Control From Ambulatory and Clinic Blood Pressure Measurements in Hypertensive Kidney Disease , 2009, Hypertension.

[25]  Colin M. Shapiro,et al.  STOP Questionnaire: A Tool to Screen Patients for Obstructive Sleep Apnea , 2008, Anesthesiology.

[26]  W. Ray,et al.  Adjustment for Multiple Cardiovascular Risk Factors Using a Summary Risk Score , 2008, Epidemiology.

[27]  Yan Li,et al.  Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study , 2007, The Lancet.

[28]  T. Pickering The Natural History of Hypertension: Prehypertension or Masked Hypertension? , 2007, Journal of clinical hypertension.

[29]  Renata Cifkova,et al.  Erratum: Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology (Journal of Hypertension (2007) 25, (1105-1187)) , 2007 .

[30]  E. O’Brien,et al.  The International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO): protocol and research perspectives , 2007, Blood pressure monitoring.

[31]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[32]  Piotr Ponikowski,et al.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.

[33]  Roberto Sega,et al.  Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure , 2006, Hypertension.

[34]  Tine Willum Hansen,et al.  Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. , 2006, American journal of hypertension.

[35]  R. Touyz Canadian hypertension education program 2006 recommendations , 2006 .

[36]  Daichi Shimbo,et al.  Ambulatory blood-pressure monitoring. , 2006, The New England journal of medicine.

[37]  Yutaka Imai,et al.  Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. , 2005, Journal of the American College of Cardiology.

[38]  Alice Stanton,et al.  Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality: The Dublin Outcome Study , 2005, Hypertension.

[39]  T. Hansen,et al.  P-65 MP-16: Ambulatory blood pressure monitoring and risk of cardiovascular disease , 2005 .

[40]  W. Rosamond,et al.  Cardiovascular disease event classification in the Jackson Heart Study: methods and procedures. , 2005, Ethnicity & disease.

[41]  Lynette Ekunwe,et al.  Study design for genetic analysis in the Jackson Heart Study. , 2005, Ethnicity & disease.

[42]  H. Taylor,et al.  The Jackson Heart Study: an overview. , 2005, Ethnicity & disease.

[43]  Daniel W. Jones,et al.  Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. , 2005, Ethnicity & disease.

[44]  Gregory Evans,et al.  Laboratory, Reading Center, and Coordinating Center Data Management Methods in the Jackson Heart Study , 2004, The American journal of the medical sciences.

[45]  KristinaBjörklund,et al.  Isolated Ambulatory Hypertension Predicts Cardiovascular Morbidity in Elderly Men , 2003 .

[46]  T. Pickering,et al.  Masked hypertension. , 2002, Hypertension.

[47]  J. Erlanger,et al.  STANDARD METHOD FOR TAKING AND RECORDING BLOOD PRESSURE READINGS , 1939 .

[48]  W. L. Curtis SULFANILAMIDE IN TREATMENT OF TULAREMIA , 1939 .